- Joined
- Apr 5, 2007
- Messages
- 5,931
Everyone saw what happened with GLPs.
They were made for diabetes, then obesity… and now they’re everywhere in bodybuilding. Especially Reta. That escalated fast.
Now trevogrumab is just starting to circulate. I know we had a thread on here last year discussing them being a few years away and now they’re here.
So it’s not whether guys will try it — they will. The real question is whether it takes off like GLPs did.
GLPs made sense for competitors. Appetite control. Staying tighter in prep. Managing insulin sensitivity. There was a clear reason to use them.
Trevogrumab was studied for muscle wasting and dystrophy. That’s not enhanced bodybuilders already running high-dose gear, GH, insulin, and pushing serious training volume.
If myostatin was the big limiter, the guys running grams would already look drastically different.
From what we’ve seen with this class, increases in lean mass don’t always equal strength or actual performance. And stacking a monoclonal antibody on top of heavy androgens and high mechanical load is unknown territory long-term.
Personally, if I want more size, I’d rather adjust food, training, recovery, or even gear before jumping to a biologic designed for disease states.
That’s just my perspective.
Curious to hear from anyone actually running it or planning to. Do you think this becomes the next GLP wave, or is this just early hype?
They were made for diabetes, then obesity… and now they’re everywhere in bodybuilding. Especially Reta. That escalated fast.
Now trevogrumab is just starting to circulate. I know we had a thread on here last year discussing them being a few years away and now they’re here.
So it’s not whether guys will try it — they will. The real question is whether it takes off like GLPs did.
GLPs made sense for competitors. Appetite control. Staying tighter in prep. Managing insulin sensitivity. There was a clear reason to use them.
Trevogrumab was studied for muscle wasting and dystrophy. That’s not enhanced bodybuilders already running high-dose gear, GH, insulin, and pushing serious training volume.
If myostatin was the big limiter, the guys running grams would already look drastically different.
From what we’ve seen with this class, increases in lean mass don’t always equal strength or actual performance. And stacking a monoclonal antibody on top of heavy androgens and high mechanical load is unknown territory long-term.
Personally, if I want more size, I’d rather adjust food, training, recovery, or even gear before jumping to a biologic designed for disease states.
That’s just my perspective.
Curious to hear from anyone actually running it or planning to. Do you think this becomes the next GLP wave, or is this just early hype?












































































